Herantis Creates Video to Show How Its Parkinson’s Therapy Works

Herantis Creates Video to Show How Its Parkinson’s Therapy Works
Herantis Pharma has created an educational video about the way its Parkinson’s treatment CDNF works. The explainer comes as the company has begun recruiting patients for a Phase 1/2 clinical trial (NCT03295786) of the potential therapy. Hallmarks of Parkinson’s include damage to dopamine-producing nerve cells in a brain area called the substantia nigra, toxic accumulation of alpha-synuclein protein clumps in nerve cells, and chronic brain inflammation. ... read more
Source: Parkinson’s News TodayPublished on 2018-04-09By Marta Figueiredo